ѧÊõÌÃÊ×Ò³ | ÎÄÏ×ÇóÖúÂÛÎÄ·¶ÎÄ | ÂÛÎÄÌâÄ¿ | ²Î¿¼ÎÄÏ× | ¿ªÌⱨ¸æ | ÂÛÎĸñʽ | ÕªÒªÌá¸Ù | ÂÛÎÄÖÂл | ÂÛÎIJéÖØ | ÂÛÎÄ´ð±ç | ÂÛÎÄ·¢±í | ÆÚ¿¯ÔÓÖ¾ | ÂÛÎÄд×÷ | ÂÛÎÄPPT
ѧÊõÌÃרҵÂÛÎÄѧϰƽ̨Äúµ±Ç°µÄλÖãºÑ§ÊõÌà > ҽѧÂÛÎÄ > ÖÐҽѧÂÛÎÄ > ÖÐÒ½ÑÛ¿ÆÂÛÎÄ

»Æ°ßË®Ö׵IJ¡Òò²¡»úºÍÖÐÒ½±æÖ¤ÂÛÖÎ

À´Ô´£ºÖйúÖÐÒ½ÑÛ¿ÆÔÓÖ¾ ×÷ÕߣºÅíÇ廪;ÔøÖ¾³É;Åí¿¡;
·¢²¼ÓÚ£º2020-07-23 ¹²8148×Ö

¡¡¡¡Õª    Òª£º¡¡±¾ÎľͻưßË®ÖײúÉúµÄÖÐÒ½²¡Òò²¡»ú¡¢±æÖ¤ÂÛÖμ°Ç²·½ÓÃÒ©ÌØÉ«½øÐÐÁËÏêϸ²ûÊö¡£ÈÏΪµ¼Ö»ưßË®Ö×µÄÖ±½Ó²¡»úÊǓѪðöˮͣ”£¬¸Ã²¡»ú²úÉú¶àÓëƢʧ½¡ÔË¡¢¸ÎʧÊèй¡¢ÉöÑôÆø»¯Ê§Ë¾¼°ÆøÒõ¿÷ÐéµÈÆø»úÔ˶¯ÕÏ°­Óйء£»îѪÀûË®·¨Ó¦¹á´©»Æ°ßË®Ö×ÖÎÁÆʼÖÕ£¬Í¬Ê±Ó¦×ñÑ­ÖÎË®¡¢ÖÎѪ±ØÖÎÆøµÄÔ­Ôò£¬ÅäºÏ½¡Æ¢ÒæÆø¡¢Êè¸Î½âÓô¡¢ÎÂÑôÒæÆø¡¢ÒæÆøÑøÒõ¼°ÀíÆøÐÐÖ͵ÈÖÎÆøÖ®·¨¡£ÀûË®ÉøʪҩÎﳵǰ×ÓÔÚÖÎÁƻưßË®Ö×¹ý³ÌÖпÉÖØÓ㬳£ÓÃÁ¿Îª20¡«30 g£¬×î´ó¼ÁÁ¿¿É´ï60 g£¬Õâ¶Ô»Æ°ßË®Ö×ÖÎÁÆ¿ÉÊÕÒâÏë²»µ½Ö®Ð§¡£ÎÄÕ»¹¶Ô»Æ°ßË®Ö×µÄÖÐÒ½ÖÎÁƽøÐÐÁ˲¡°¸¾ÙÓç¡£

¡¡¡¡¹Ø¼ü´Ê£º¡¡»Æ°ßË®Ö×; Ѫðöˮͣ; »îѪÀûË®; ÖÎÆø; ³µÇ°×Ó;

¡¡¡¡Abstract£º¡¡In this paper, the etiology and pathogenesis of macular edema in Traditional Chinese Medicine, syndrome differentiation and treatment, as well as the characteristics of the use of prescription and drugs were discussed in detail. It was believed that the direct pathogenesis of macular edema was blood stasis and water retention, which was mainly related to dysfunction of spleen in transportation, liver dysfunction, kidney Yang qi dysfunction and qi-yin deficiency. The method of promoting blood circulation and inducing diuresis should be used throughout the treatment of macular edema. At the same time, it should follow the principle that the treatment for water and blood must first treat the qi, and cooperate with the method of strengthening the spleen and replenishing qi, dispersing stagnated liver qi to relieve qi stagnation, warming Yang and benefiting qi, benefiting qi and nourishing yin and regulating qi-flowing to activate stagnancy. Plantain seed having the effect of inducing diuresis and excreting dampness could be reused in the treatment of macular edema. The common dose was 20¡«30 g, and the maximum dose could reach to 60 g, which had unexpected effect on the treatment of macular edema. The article also gave a medical record about macular edema with the TCM treatment.

¡¡¡¡Keyword£º¡¡macular edema; blood stasis and water retention; promoting blood circulation and inducing diuresis; treating the qi; plantain seed;

¡¡¡¡»Æ°ßË®Ö×ÊÇÓÉÓÚ¶àÖÖÒòËص¼ÖÂÊÓÍøĤëϸѪ¹Üͨ͸ÐÔÔö¼Ó¡¢Ñª-ÊÓÍøĤÆÁÕÏÊÜËð£¬ÒºÌå»ý¾ÛÔÚÊÓÍøĤ»Æ°ßÍâ´Ô×´²ãºÍÄں˲ãÖ®¼ä£¬³£¼Ì·¢ÓÚÊÓÍøĤ¾²Âö×èÈû¡¢ÌÇÄò²¡ÊÓÍøĤ²¡±ä¡¢ÆÏÌÑĤÑ׺ÍÊÓÍøĤѪ¹ÜÑס¢ÑÛÍâÉ˼°ÄÚÑÛÊÖÊõºóµÈ¼²²¡¡£»Æ°ßË®Ö׸ù¾ÝÁÙ´²±íÏÖ³£·ÖΪ»Æ°ßÄÒÑùË®Ö׺ÍÃÖÂþÐԻưßË®Ö×£¬»¼Õß³£°éÓÐÊÓÁ¦Ï½µ¡¢ÊÓÎï±äÐεÈÖ¢×´¡£Ä¿Ç°³£ÓõÄÖÎÁÆ·½·¨Óв£Á§ÌåÇ»ÄÚ×¢ÉäÇú°²Äε»ò¿¹Ñª¹ÜÄÚƤÉú³¤Òò×Ó£¨vascular endothelial growth factor,VEGF£©Ò©Îï¡¢²£Á§ÌåÇгý+ÄÚ½çĤ°þ³ýÊõ£¬ÆäÖнüÄê²£Á§ÌåÇ»×¢É俹VEGFÒ©ÎïÖÎÁƻưßË®Ö×È¡µÃÁ˽ϺõÄÊÓÁ¦ºÍ½âÆʸ´Î»Ð§¹û£¬µ«Ò©Ð§ÄÑÒԳ־ã¬ÐèÒª·´¸´×¢Éä[1]¡£Òò´Ë£¬¼õÉÙ¸´·¢¡¢¹®¹ÌÁÆЧ³ÉΪĿǰÁÙ´²ÖÎÁƻưßË®Ö×ÐèÒª½â¾öµÄÎÊÌâ¡£

¡¡¡¡±¾ÎĽ«´ÓÖÐҽѧÀíÂÛ³ö·¢£¬¶Ô»Æ°ßË®Ö׵IJ¡Òò²¡»ú¡¢±æÖ¤ÂÛÖΡ¢Ç²·½ÓÃÒ©Ìصã½øÐвûÊö£¬²¢½øÐÐÖÐÒ½Ò©ÖÎÁƲ¡°¸¾ÙÓç¡£

¡¡¡¡1¡¢ »Æ°ßË®Ö׵IJ¡Òò²¡»ú

¡¡¡¡»Æ°ßË®Ö×£¬Æ䲡Àí²úÎïΪ“ÄÚÉúˮʪ”£¬Êô½òÒº´úлʧ³£¡¢“ˮͣ”µÄ²¡Àí·¶³ë¡£¡¶½ðØÑÒªÂÔ·Ë®Æø²¡ÂöÖ¤²¢ÖΡ·[2]Ô»£º“Ѫ²»ÀûÔòΪˮ”£¬¡¶ÑªÖ¤ÂÛ¡·[3]ÖÐÒ²Ö¸³ö£º“Ѫ»ý¼È¾Ã£¬ÒàÄÜ»¯ÎªÌµË®¡£”“Ѫ²»Àû”¼´ÎªÑªÁ÷²»³©»òѪÒçÂöÍâµÈ“Ѫðö”²¡Àí±íÏÖ£¬¿Éµ¼ÖÂÂöÍâÖ®½òÒº»·Á÷²»Àû£¬ÒàÖÂÆøÖÍ£¬´Ùʹ½òͣΪˮ¡£½áºÏÏÖ´úҽѧÈÏʶµÄѪ¹ÜËðº¦ÔڻưßË®Ö×·¢ÉúÖеÄ×÷Óã¬ÈÏΪµ¼Ö»ưßË®ÖדÄÚÉúˮʪ”µÄ²úÉúÓë“Ѫ²»Àû”“Ѫðö”¹ØϵÃÜÇУ¬“Ѫðöˮͣ”ÊÇÆäÖ±½Ó²¡»ú[4]¡£

¡¡¡¡»Æ°ßÊôÆ¢£¬Ä¿Îª¸ÎÇÏ£¬Í«ÉñÊôÉö¡£“ÖîʪÖ×Âú£¬½ÔÊôÓÚÆ¢”£¬Æ¢Ö÷ÔË»¯Ë®Òº£¬ÈôÆ¢ÆøÐéË¥£¬ÆøÐéÐÐѪÎÞÁ¦¡¢ÔËÐнòÒº¹¦ÄÜÕÏ°­£¬ÔòѪÂöðöÖÍ¡¢Ë®ÊªÄÚÉú£»¸ÎÆøͨÓÚÄ¿£¬“¸ÎºÍÔòÄ¿ÄܱæÎåÉ«”£¬¸ÎÖ÷Êèй£¬µ÷³©Æø»ú£¬ÆøÐÐÔòѪÐУ¬ÆøÐÐÔòË®ÐУ¬´Ù½øѪҺ¡¢½òÒºµÄÊä²¼£¬Èô¸ÎʧÊèй£¬Æø»úÓô½á£¬ÍùÍùµ¼ÖÂѪÐÐðöÖÍ£¬ÑªÒº¼°½òÒºÒç³öÂöÍ⣬ˮʪͣÖÍ£»ÉöÑôÆø»¯£¬ÊÇѪҺ»¯Éú¡¢Ñ­ÐС¢½òÒºÊä²¼µÄÖØÒª±£Ö¤£¬ÉöÑô¿÷Ð飬ÎÂìãÍƶ¯ÎÞÁ¦£¬Ò²½«µ¼ÖÂѪʧͨ³©£¬ÂöµÀɬÖͶøÖÂѪðö£¬½òÒº²»µÃÆø»¯£¬Êª´ÓÄÚÉú¡£Ïû¿Ê²¡»¼Õߣ¬ÒõÐéΪ±¾£¬ÔïÈÈΪÆä±ê£¬ÒõÐéÔïÈÈÈվÿֽ«ºÄÆøÉËÒõ£¬ÆøÒõÁ½Ð飬Æø²»Ô˾«£¬×ÇаÉÏ·ºÇåÇÏ£¬Ë®ÊªÄý¾Û²»É¢£»Í¬Ê±ÆøÐéÔòÍƶ¯ÎÞÁ¦£¬Òõ¿÷ÔòѪÐв»³©£¬ÈÕ¾ÃѪðöÂöÖУ¬“Ѫ²»ÀûÔòΪˮ”£¬¹Ê¶øÑÛµ×ÂöÂçðöÖÍ£¬Ë®ÊªÄý¾Û£¬³öÏֻưßË®Öס¢Éø³ö¡£¹Êµ¼Ö»ưßË®ÖדѪðöˮͣ”²¡»ú²úÉú¶àÓëƢʧ½¡ÔË¡¢¸ÎʧÊèй¡¢ÉöÑôÆø»¯Ê§Ë¾¼°ÆøÒõ¿÷ÐéµÈÆø»úÔ˶¯ÕÏ°­µÈ²¡ÒòÓйء£
 

»Æ°ßË®Ö׵IJ¡Òò²¡»úºÍÖÐÒ½±æÖ¤ÂÛÖÎ
 

¡¡¡¡2¡¢ »Æ°ßË®Ö׵ıæÖ¤ÂÛÖÎ

¡¡¡¡“Ѫðö”Êǻư߲¿·¢Éú“ˮͣ”µÄÖ±½Ó²¡Àí»úÖÆ£¬»îѪÀûË®ÔòÊÇÆäÖÎÁƵÄÖ÷Òª·¨Ôò¡£µ«Öβ¡±ØÇóÓÚ±¾£¬Õë¶Ô“ˮͣ”²ÉÓÓÀûË®Éøʪ·¨”ÊÇÖα꣬“Ѫðö”²ÉÓÓ»îѪ»¯ðö·¨”ÊÇÖα¾ÖÐÖ®±ê£¬Ö»ÓÐÖÎÁÆÒýÆð“Ѫðöˮͣ”µÄ¸ù±¾²¡Òò²ÅÊÇÖα¾ÖÐÖ®±¾£¬ÖÎÁÆÉÏÓ¦±ê±¾¼æÖΡ£¶øµ¼Ö»ư߲¿“Ѫðöˮͣ”µÄ¸ù±¾Ô­ÒòÓë¸Î¡¢Æ¢¡¢ÉöÔอÆø»ú¹¦ÄÜʧµ÷»òÈ«ÉíÆøÒõ¿÷ÐéÓйء£

¡¡¡¡2.1¡¢ Æ¢Ðéˮ֤ͣ

¡¡¡¡Ö¤ºò£ºÊÓÎïÄ£ºý£¬»òÊÓÎï±äÐΣ¬ÊÓÍøĤÉø³ö£¬»ò¼ûÊÓÍøĤµãƬ״³öѪ£¬»Æ°ß²¿Ë®Ö×£»¾ëµ¡ÀÁÑÔ£¬Ãæɫή»Æ£¬Ê³ÉÙ¸¹ÕÍ£¬´ó±ãÏ¡ä磻É൭ÅÖ£¬Ì¦°×£¬Âö»º»ò妡£Ö稣º½¡Æ¢ÒæÆø£¬»îѪÀûË®¡£·½Ò©£º²ÎÜß°×ÊõÉ¢¼Ó¼õ¡£µ³²Î10 g¡¢ÜòÜß15 g¡¢°×Êõ10 g¡¢Ö˸ʲÝ6 g¡¢É½Ò©10 g¡¢°×±â¶¹10 g¡¢Þ²ÜÓÈÊ15 g¡¢½Û¹£10 g¡¢É°ÈÊ3 g¡¢Á«×ÓÈâ10 g¡¢³ÂƤ3 g¡¢³µÇ°×Ó£¨²¼°ü£©20¡«30 g¡¢ÖíÜß15 g¡¢ÔóÀ¼10 g¡¢Òæĸ²Ý15 g¡£¼Ó¼õÓ¦ÓãºÈô¼ûÐÂÏʳöѪ£¬ÑªÉ«Ïʺ죬¼Óĵµ¤Æ¤10 g¡¢³´ÆÑ»Æ10 g£¨°ü¼å£©ÒÔÁ¹ÑªÖ¹Ñª¡£Èô¼û³Â¾ÉÐÔ³öѪ£¬ÑªÉ«×Ï°µ£¬¼ÓÌÒÈÊ10 g¡¢ºì»¨6 gÒÔ»îѪ»¯ðö¡£Èô¼û»ú»¯Ä¤¼°³Â¾ÉÐÔÉø³öÕߣ¬¼ÓÀ¥²¼10 g¡¢º£Ôå10 gÒÔÈí¼áÉ¢½á¡£

¡¡¡¡2.2¡¢ ¸ÎÓôˮ֤ͣ

¡¡¡¡Ö¤ºò£ºÊÓÎïÄ£ºý£¬»òÕßÊÓÎï±äÐΣ¬ÊÓÍøĤÉø³ö£¬»ò¼ûÊÓÍøĤµãƬ״³öѪ£¬»Æ°ß²¿Ë®Ö×£»Ð²ÀßÕÍÍ´£¬ÉÆÌ«Ï¢£¬ÇéÖ¾ÒÖÓô»ò¼±ÔêÒ×Å­£»Éà̦°×»òÄ壬ÂöÏÒ¡£Ö稣ºÊè¸ÎÀíÆø£¬»îѪÀûË®¡£·½Ò©£ºåÐңɢ¼Ó¼õ¡£²ñºú10 g¡¢µ±¹é12 g¡¢°×ÉÖ15 g¡¢°×Êõ10 g¡¢ÜòÜß15 g¡¢Ö˸ʲÝ6 g¡¢³µÇ°×Ó£¨²¼°ü£©20¡«30 g¡¢ÖíÜß15 g¡¢ÔóÀ¼10 g¡¢Òæĸ²Ý15 g¡£¼Ó¼õÓ¦ÓãºÈô¸ÎÓô·¢ÈÈ£¬¼±ÔêÒ×Å­Õߣ¬¼Óĵµ¤Æ¤10 g¡¢èÙ×Ó10 gÒÔƽ¸ÎÇåÈÈ£»ÈôÄÉ´ô¸¹ÕÍ£¬´ó±ãÏ¡äçÕߣ¬¼Óɽҩ10 g¡¢°×±â¶¹10 g¡¢É°ÈÊ3 gÒÔ½¡Æ¢ÀíÆø£»Èô¼ûÐÂÏʳöѪ£¬¼Óĵµ¤Æ¤10 g¡¢³´ÆÑ»Æ10 g£¨°ü¼å£©ÒÔÁ¹ÑªÖ¹Ñª£»¼û³Â¾ÉÐÔ³öѪ£¬¼ÓÌÒÈÊ10 g¡¢ºì»¨6 gÒÔ»îѪ»¯ðö¡£

¡¡¡¡2.3¡¢ ÑôÐéˮ֤ͣ

¡¡¡¡Ö¤ºò£ºÊÓÎïÄ£ºý£¬»òÕßÊÓÎï±äÐΣ¬ÊÓÍøĤÉø³ö£¬»ò¼ûÊÓÍøĤµã¡¢Æ¬×´³öѪ£¬»Æ°ß²¿Ë®Ö×£»ÃæÉ«»Î°×£¬Ö«Ì帡Ö×£¬ÉÙÆøÀÁÑÔ£¬ÉñÆ£·¦Á¦£¬Î·º®Ö«À䣻ÉàÖʵ­ÅÖ£¬Ì¦°×£¬Âö³Áϸ»ò³Á³ÙÎÞÁ¦¡£Ö稣ºÎÂÑôÒæÆø£¬»îѪÀûË®¡£·½Ò©£ºÕæÎäÌÀºÏ²¹Ñô»¹ÎåÌÀ¼Ó¼õ¡£ÖƸ½×Ó10 g£¨Ïȼ壩¡¢ÜòÜß15 g¡¢°×Êõ10 g¡¢¸É½ª6 g¡¢³àÉÖ10 g¡¢»ÆÜÎ30 g¡¢´¨Üº10 g¡¢µ±¹éβ12 g¡¢ÌÒÈÊ10 g¡¢ºì»¨6 g¡¢Òæĸ²Ý15 g¡¢³µÇ°×Ó20¡«30 g£¨°ü¼å£©¡£¼Ó¼õÓ¦Óãºë丹ÀäÍ´£¬´ó±ãäçк£¬¼Ó²¹¹ÇÖ¬10 g¡¢ÎâÜïÝÇ10 gÒÔβ¹Æ¢Éö£¬É¬³¦Ö¹Ðº£»Î·º®Ö«Àä½ÏÉõ£¬¼ÓÈâ¹ð3 g£¬ÒÔÎÂÑôͨÂö¡£

¡¡¡¡2.4 ¡¢ÆøÒõÁ½Ð顢Ѫðöˮ֤ͣ

¡¡¡¡Ö¤ºò£ºÊÓÁ¦Ï½µ£¬»òÕßÊÓÎï±äÐΣ¬»òÑÛÇ°ºÚÓ°Æ®¶¯£¬ÊÓÍøĤÉø³ö¡¢³öѪ£¬»Æ°ßË®Ö×£»ÃæÉ«ÉÙ»ª£¬ÉñÆ£·¦Á¦£¬ÉÙÆøÀÁÑÔ£¬×Ôº¹£¬ÑʸɿÚÔÎåÐÄ·³ÈÈ£»É൭£¬ÂöÐéÎÞÁ¦¡£Ö稣ºÒæÆøÑøÒõ£¬»îѪÀûË®¡£·½Ò©£ºÉúÂöÉ¢ºÏÁùζµØ»ÆÍè¼Ó¼õ¡£È˲Î10 g¡¢Îåζ×Ó10 g¡¢Âó¶¬10 g¡¢ÊìµØ»Æ15 g¡¢É½ÜïÝÇ6 g¡¢É½Ò©15 g¡¢Ôóк15 g¡¢ÜòÜß15 g¡¢Äµµ¤Æ¤10 g¡¢³µÇ°×Ó20¡«30 g£¨°ü¼å£©¡¢³àÉÖ10 g¡¢µ¤²Î10 g¡¢Òæĸ²Ý15 g¡£¼Ó¼õÓ¦ÓãºÑÛµ×ÓÐÐÂÏʳöѪÕߣ¬ÑªÉ«Ïʺ죬¼Ó³´ÆÑ»Æ10 g£¨°ü¼å£©¡¢Å®Õê×Ó10 g¡¢ºµÁ«²Ý10 gÒÔ×ÌÒõÁ¹Ñª£»Ñ۵׳öѪɫ×Ï°µÕߣ¬¼ÓÌÒÈÊ10 g¡¢ºì»¨6 g¡¢ÈýÆß·Û3 g£¨³å·þ£©ÒÔÔöÇ¿»îѪ»¯ðöÖ®¹¦£»ÐÄ·³Ê§ÃßÕß¼ÓËáÔæÈÊ12 g¡¢Ò¹½»ÌÙ10 gÒÔÑøÐÄ°²Éñ¡£

¡¡¡¡3 ¡¢»Æ°ßË®Ö×µÄDz·½ÓÃÒ©Ìصã

¡¡¡¡3.1 ¡¢»îѪÀûË®·¨¹á´©»Æ°ßË®Ö×ÖÎÁÆʼÖÕ

¡¡¡¡»îѪÀûË®·¨ÊÇÖ¸ÓÉ»îѪ»¯ðöÒ©ÎïºÍÀûË®ÉøʪҩÎﹲͬ×é³É£¬ÊÇѪˮ»¥½á»òѪðöˮ֤ͣµÄÖÎÁÆ·¨Ôò£¬±¾È˼°ÍŶÓÓÚÉÏÊÀ¼Í90Äê´ú³õÔÚ¹úÄÚ×îÔçÌá³öÑÛ¿ÆˮѪͬÖεÄÀíÂÛ[5,6]ºó£¬¸ÃÖη¨ÒѾ­¹ã·ºÔËÓÃÓÚÑÛ¿ÆѪˮ»¥½á»òѪðöˮ֤ͣµÄÖÎÁÆ¡£ÉúÀíÉÏѪˮͬԴ£¬²¡ÀíÉÏѪˮ´úлÏ໥ӰÏì¡£¡¶ÁéÊà·Ó¸¾Ò¡·[7]ÔÆ£º“½òÒººÍµ÷£¬±ä»¯¶ø³àΪѪ”£¬ËµÃ÷Ë®¡¢Ñª¾ùÀ´×ÔÓÚÒûʳÎïµÄË®¹È¾«Î¢£¬»¯ÉúÓÚºóÌìƢ裬¹ÊÓГ½òѪͬԴ”֮˵£»Í¬Ê±£¬Ë®ÓëѪÓÖ»¥ÎªÉú»¯Ö®Ô´£¬È硶ÁéÊà·Ð°¿Í¡·[7]Ô»£º“ÓªÆøÕߣ¬ÃÚÆä½òÒº£¬×¢Ö®ÓÚÂö£¬»¯ÒÔΪѪ”£¬ËµÃ÷ÓªÆø·ÖÃڵĽòÒº£¬Éø×¢µ½¾­ÂöÖ®ÖУ¬±ä»¯ÎªÑªÒº£¬ÑªÒºÑ­¾­ÔËÐУ¬ÔÚÒ»¶¨Ìõ¼þÏ£¬ÑªÒºÖеIJ¿·ÖˮҺÉø³öÓÚÂöÍ⣬ÓëÂöÍâµÄ½òÒº»¯ºÏÔÚÒ»Æ𣬶ø³ÉΪ½òÒºµÄÒ»²¿·Ö¡£²¡ÀíÉÏ£¬ÑªÒº×èÖÍÂöÂ磬ÂöÖнòÒºÉø³öÂöÍâ¶øΪˮҺ£¬·¢Îª²¡Àí֮ˮ¡£¡¶ÑªÖ¤ÂÛ¡·[3]ÖÐÖ¸³ö£º“¹Ê²¡ÑªÕßδ³¢²»²¡Ë®£¬²¡Ë®ÕßÒàδ³¢²»²¡ÑªÒ²”“ʧѪ¼ÒÍùÍùË®Ö×£¬ðöѪ»¯Ë®Òà·¢ÉúË®Ö×£¬ÊÇѪ²¡¶ø¼æˮҲ”£¬·´¸´Ç¿µ÷ÁËË®¶ôѪðö¡¢ÑªðöˮͣµÄ²¡Àí¹Øϵ¡£

¡¡¡¡ÏÖ´úҽѧÈÏΪ£¬»Æ°ßË®Ö׵ķ¢²¡»úÖÆÖ÷ÒªÊÇÓÉÓڻưßÇøëϸѪ¹ÜÊÜËð£¬Ñª-ÊÓÍøĤÆÁÕÏÆÆ»µ£¬ÊÓÍøĤÉø©Һ»ý¾ÛÓÚÍâ´Ô×´²ãÓëÄں˲ãÖ®¼ä¡£Ò»Ð©È«ÉíÒòËØ£¨Èç¸ßѪѹ²¡¡¢ÌÇÄò²¡¡¢ÑªÖ¬´úлÒì³££©¿ÉÄܵ¼ÖÂÊÓÍøĤѪ¹ÜÄÚƤϸ°ûËðÉË£¬ÑªÁ÷¶¯Á¦Ñ§¸Ä±ä£¬Óɴ˵¼ÖÂÊÓÍøĤȱѪȱÑõ£¬VEGF±í´ïÉϵ÷£¬VEGFÓÖÓëÆäÌØÒìÐÔÊÜÌå½áºÏ£¬´Ì¼¤Ï¸°û¼ä𤸽·Ö×Ó-1ºÍѪ¹Üϸ°û¼ä𤸽·Ö×Ó·ÖÃÚ£¬´Ù½øÊÓÍøĤëϸѪ¹ÜÄÚ°×ϸ°û𤸽£¬Æô¶¯Ñ×Ö¢·´Ó¦[8,9]£¬Í¬Ê±ÓÕµ¼ÄÚƤϸ°ûÖ§¼Üµ°°×ºÍ𤸽µ°°×Á×Ëữ£¬´Ì¼¤ÊÓÍøĤɫËØÉÏƤϸ°ûÖ®¼ä½ôÃÜÁ¬½Óµ°°×¡¢±ÕËøµ°°×µÄÁ×Ëữ£¬¸Ä±äϸ°ûÁ¬½Ó¹¹Ï󣬽øÒ»²½¸Ä±äÊÓÍøĤëϸѪ¹ÜµÄͨ͸ÐÔ£¬Ñª-ÊÓÍøĤÆÁÕÏÔâµ½ÆÆ»µ£¬ÒºÌåÓÉѪ¹ÜÄÚÏò×éÖ¯¼ä϶Éø©£¬Ï¸°ûÍâ¼ä϶À©´ó£¬ÒºÌå»ý¾Û[10]£»ÁíÍâVEGF»¹ÄÜ´ÙÓÐË¿·ÖÁÑËØÓëÄÚƤϸ°ûÊÜÌå½áºÏ¶øÒýÆðÄÚƤϸ°ûÔöÖ³²¢ÐγÉÐÂÉúѪ¹Ü£¬¸Ä±äѪ¹ÜÉø͸ÐÔ£¬¼Ó¿ìѪ-ÊÓÍøĤÆÁÕϵÄÆÆ»µ´Ó¶ø½øÒ»²½´Ùʹ»Æ°ßË®Ö×·¢Éú·¢Õ¹[11]¡£Ñª¹ÜÄÚƤϸ°ûËðÉË¡¢VEGF±í´ïÉϵ÷¼°ÐÂÉúѪ¹ÜÐγÉÊǓѪ²»Àû”»ò“Ѫðö”²¡Àí¸Ä±äµÄ¾ßÌåÄÚº­Ö¸±ê[12]£»ÊÓÍøĤÉø©Һ»ý¾ÛÓÚÊÓÍøĤ»Æ°ßÍâ´Ô×´²ãºÍÄں˲ãÖ®¼ä£¬ÊǓˮʪÄÚÍ£”ÓÚÑ۵׻ư߲¿µÄÖ±½Ó±íÕ÷¡£¹Ê»îѪÀûË®·¨Ó¦¸Ã¹á´©»Æ°ßË®Ö×ÖÎÁƵÄʼÖÕ¡£

¡¡¡¡³£ÓõĻîѪÀûˮҩÎï°üÀ¨Æѻơ¢µ¤²Î¡¢µ±¹éβ¡¢´¨Üº¡¢³àÉÖ¡¢µØÁú¡¢ÈýÆß¡¢ÌÒÈÊ¡¢ºì»¨¡¢ÈýÀ⡢ݭÊõ¡¢ÜòÜß¡¢°×Êõ¡¢Ôóк¡¢ÖíÜß¡¢ÔóÀ¼¡¢³µÇ°×Ó¡¢Òæĸ²ÝµÈ¡£µ«ÊÇÔÚÔËÓÓ»îѪÀûË®·¨”ÖÎÁƻưßË®Ö׵Ĺý³ÌÖУ¬ÐèҪעÒâÒÔÏÂÈý¸ö·½Ãæ¡££¨1£©¸ù¾ÝÑÛµ×Ѫ¹ÜÔìÓ°£¨fundus fluorescein angiography,FFA£©¼ì²é½á¹û£¬Èç·¢ÏÖÎÞ¹à×¢Çø¼°ÐÂÉúѪ¹ÜÐγɣ¬ÔÚÔËÓÃÖÐÒ½Ò©ÖÎÁÆͬʱ£¬»¹±ØÐëÔËÓÃÊÓÍøĤ¼¤¹â¹âÄýÊõ£¬Í¨¹ýÖ±½Ó·â±ÕÊÓÍøĤëϸѪ¹ÜÎÞ¹à×¢Çø£¬Ô¤·ÀÐÂÉúѪ¹ÜÐγɻò´ÙʹÐÂÉúѪ¹ÜήËõ£¬·ÀÖ¹·´¸´³öѪºÍÉø©µÄ·¢Éú¡££¨2£©ÔÚÖÐÒ½Ò©ÖÎÁƻưßË®Ö×¹ý³ÌÖУ¬ÓÉÓڻưßË®Ö×ÍùÍùÓëÑ۵׳öѪͬʱ³öÏÖ£¬ÐèÒª¸ù¾Ý·¢²¡Ê±¼ä¡¢³öѪÑÕÉ«µÈÁé»îÔËÓÓ»îѪ”·¨Ôò¡£·¢²¡°ë¸öÔÂÄÚ£¬³öѪ¿ªÊ¼»òΪ³öѪ»î¶¯ÆÚ£¬ÑÛµ×¼ì²é¼ûÊÓÍøĤ¼ûµã×´¡¢Æ¬×´ÏʺìÉ«³öѪ£¬ÖÎÁÆÉÏÓ¦ÒÔֹѪΪҪ£¬¼æ¹Ë»îѪ£¬Ò©Óó´Æѻơ¢Äµµ¤Æ¤¡¢ºµÁ«²Ý¡¢°×é¸ù¡¢ÈýÆߵȻîѪֹѪ֮Ʒ£»·¢²¡°ë¸öÔÂÖÁ2¸öÔÂÖ®¼ä£¬ÑÛµ×¼ì²é¼ûÊÓÍøĤ³öѪÑÕÉ«×Ï°µ£¬Ó¦ÒÔ»îѪ»¯ðö¡¢ÐÐÆøµ¼ÖÍΪÖ÷£¬Ò©ÓÃÌÒÈÊ¡¢ºì»¨¡¢µØÁú¡¢³àÉÖ¡¢´¨Üº¡¢Ï㸽¡¢Òæĸ²ÝµÈÐÐÆø»îѪ£»·¢²¡2¸öÔº󣬲¡»ýÈվã¬ÑÛµ×¼ûѪɫ÷öºÚ£¬²¿·Ö³öѪÎüÊÕ£¬»ú»¯¿ªÊ¼Ðγɣ¬´ËʱӦÒÔÆÆѪͨÂçÐÐðöΪÖ÷£¬ÔÚÔËÓÃÌÒÈÊ¡¢ºì»¨»îѪҩÎï»ù´¡ÉÏ£¬×üÓÈýÀ⡢ݭÊõµÈÒ©¡££¨3£©ÔÚÔËÓûîѪÀûË®·¨ÖÎÁƻưßË®Ö×¹ý³Ìµ±ÖУ¬ÈôÔอÆø»úʧµ÷Õ÷Ïó²»µäÐÍ£¬½ö¼û»Æ°ßË®Ö×£¬»ò°éÑ۵׳öѪÑÕÉ«×Ï°µ£¬ÉàÖÊ×Ï°µ£¬ÓÐðöµã¡¢ðö°ß£¬Âöɬ»òÏÒɬµÈ£¬¿ÉÖ±½ÓͶÒÔÀíÆøÐÐÖÍ»îѪìîðö֮Ѫ¸®ÖððöÌÀ£¬ÅäºÏÀûË®ÉøʪҩÎ³µÇ°×Ó¡¢ÜòÜß¡¢ÔóкµÈ£©½øÐÐÖÎÁÆ£¬Öв¡¼´Ö¹¡£

¡¡¡¡3.2¡¢ ÖÎË®ÖÎѪ±ØÖÎÆø

¡¡¡¡Æø¡¢Ñª¡¢½òÒºÊǹ¹³ÉÈËÌ塢άϵÈËÌåÉúÃü»î¶¯µÄ»ù±¾ÎïÖÊ£¬ËüÃÇÖ®¼äÉúÀíÉϽôÃÜÁªÏµ¡¢Ï໥»¯Éú¡¢Ï໥ÒÀÀµ£¬²¡ÀíÉÏÏ໥ӰÏì¡£“ÆøΪѪ֮˧”£¬ÆøÓë½òÒºµÄ¹ØϵҲÀàËÆÓÚÆøÓëѪ¡£ÆøÊôÑô£¬Ö÷¶¯£¬ÑªºÍ½òÒºÊôÒõ£¬Ö÷¾²£¬ÆøÄÜÐÐѪ£¬ÆøÄÜÉãѪ£¬ÆøÄÜÐнò£¬ÆøÄÜÉã½ò£¬Òò´Ë£¬ÆøÔÚѪºÍ½òÒºµÄÔËÐÐÊä²¼ÖÐÕ¼Ö÷µ¼µØλ¡£ÈËÌåѪ¡¢½òÒºµÄÊä²¼Óë´úл£¬¾ùÐèÒÀÀµÈ«Éí¼°Ïà¹ØÔอÆø»ú³äÅæÓëÔ˶¯Ð­µ÷£¬²ÅÄÜ·¢»Óå¦ÑøÓë×ÌÈóµÈ×÷Ó᣻ưßÊôÆ¢£¬Ä¿Îª¸ÎÇÏ£¬Í«ÉñÊôÉö£¬»Æ°ß²¿ÖÜΧѪҺºÍ½òÒºÔËÐÐʧµ÷£¬ÔòÓëÆ¢¡¢¸Î¡¢ÉöÔอÆø»úÔ˶¯Ê§µ÷ÃÜÇÐÏà¹Ø¡£¹Ê»Æ°ßË®Ö×ÖÎÁÆÔÚÔËÓûîѪÀûË®·¨Ç°ÌáÏ£¬±ØÐëÒÔ“ÖÎÆø”Ϊ»ù´¡£¬ÆøÐéÕß²¹Ö®£¬ÆøÖÍÕßÐÐÖ®£¬Æø»¯²»ÀûÕßÎÂÖ®£¬¾ßÌåÖη¨°üÀ¨½¡Æ¢ÒæÆø¡¢Êè¸ÎÀíÆø¡¢ÎÂÑôÒæÆø¼°ÒæÆøÑøÒõµÈ¡£ÕýÈçÎâ¾ÏͨÔÚ¡¶Î²¡Ìõ±æ¡·[13]ËùÑÔ£º“ÉÆÖÎË®Õߣ¬²»ÖÎË®¶øÖÎÆø”“ÉÆÖÎѪÕߣ¬²»ÇóÖ®ÓÐÐÎ֮Ѫ£¬¶øÇóÖ®ÎÞÐÎÖ®Æø¡£”

¡¡¡¡3.3 ¡¢ÀûË®ÖØÓóµÇ°×Ó

¡¡¡¡ÔÚÔËÓûîѪÀûË®·¨ÖÎÁƻưßË®Ö×ÖÐÖØÓóµÇ°×Ó£¬È¡ÆäÀûË®Ã÷Ä¿Ö®¹¦£¬³£ÓÃÁ¿Îª20¡«30 g£¬×î´ó¼ÁÁ¿¿É´ï60 g£¬¶Ô»Æ°ßË®Ö×ÖÎÁÆ¿ÉÊÕÒâÏë²»µ½Ö®Ð§¡£³µÇ°×ÓÐÔ΢º®£¬Î¶¸Ê£¬ÎÞ¶¾£¬¹éÉö¡¢¸Î¡¢·Î¾­¡£ÓÐÀûÄòͨÁÜ¡¢Éøʪֹк¡¢Çå¸ÎÃ÷Ä¿¡¢Çå·Î»¯ÌµÖ¹¿ÈÖ®¹¦Ð§¡£ÔÚ³¤ÆÚÁÙ´²Êµ¼ùÖУ¬³µÇ°×Ó±»ÈÏΪÊdz£Óá¢ÓÐЧµÄÀûË®ÉøʪÖÐÒ©£¬Í¬Ê±ÓÉÓÚÆäÓÐÇå¸ÎÃ÷Ä¿µÄ¹¦Ð§£¬ÔÚÑۿƸüÊÇÔËÓù㷺£¬ºÂÃ÷·ÒµÈ[14]¶Ô¹Å´úº¬³µÇ°×Ó¸´·½ËùÖÎÁƵIJ¡Ö¢¹¹³É½øÐÐÁË·ÖÎö·¢ÏÖ£¬º¬³µÇ°×Ó¸´·½ÒÔÖÎÁÆÑÛ²¡Õß×î¶à¡£¹¢·ÅµÈ[15]Ñо¿±íÃ÷£¬³µÇ°×Ó¾ßÓÐÀûÄò×÷Óã¬ÊÇÄÜÔö¼ÓË®¡¢µç½âÖÊÅÅйµÄÀûÄòÒ©¡£ÔøÃÎ骵È[16]Ñо¿Ò²·¢ÏÖ£¬³µÇ°×Ó¿ÉÏÔ×ÅÓ°ÏìÄÆ¡¢ÂÈÀë×Óת»»ÒÔ¼°½µµÍÉöÔàAQP1µÄ±í´ï£»´ËÍ⣬³µÇ°×ÓÓ°ÏìÉöµ¥Î»ÖÐÄÆ¡¢ÂÈÀë×ÓתÔ˵ĸº·´À¡µ÷½Ú£¬¿ÉÄÜÊÇÆä·¢»Ó³¤Ð§ÀûÄò×÷ÓõÄÔ­Òò¡£ÒÔÉÏÑо¿±íÃ÷³µÇ°×ÓÓÐÀûË®Éøʪ֮Ч£¬Ò²ÎªÆäÖÎÁƻưßË®Ö×ÌṩÁË·Ö×ÓÉúÎïѧÀíÂÛÒÀ¾Ý¡£

¡¡¡¡4 ¡¢²¡°¸¾ÙÓç

¡¡¡¡»¼Õߣ¬Åíij£¬Å®£¬56Ëê¡£2019Äê9ÔÂ16ÈÕ³õÕï¡£Ö÷Ëߣº×óÑÛÊÓÎïÄ£ºý1¸öÔÂÓà¡£»¼ÕßËß8Ô³õ×óÑÛÊÓÁ¦Í»È»Ï½µ£¬ÔÚµ±µØÒ½ÔºÑÛ¿ÆÃÅÕï¾ÍÕÐÐFFA¼ì²éÌáʾ×óÑÛÊÓÍøĤò¨ÏÂÖ§¾²Âö×èÈû£¨·ÇȱѪÐÍ£©£¬×óÑۻưßÄÒÑùË®Öס£Õï¶Ï£º£¨1£©×óÑÛÊÓÍøĤ·ÖÖ§¾²Âö×èÈû£»£¨2£©×óÑۻưßË®Öס£µ±µØÒ½ÔºÓèÒÔºÍѪÃ÷ĿƬ¿Ú·þ£¬Ð§¹ûÇ·¼Ñ£¬ËìÖÁºþÄÏÖÐÒ½Ò©´óѧµÚÒ»¸½ÊôÒ½ÔºÑۿƾÍÕï¡£ÑۿƼì²é£ºÊÓÁ¦£¬ÓÒÑÛ0.6£¬×óÑÛ0.04£¬½ÃÕý²»Ìá¸ß¡£ÑÛѹ£¬×óÑÛ14 mm Hg(1 mm Hg=0.133 kPa£©£¬Ë«ÑÛ¾§×´ÌåƤÖÊÂÖ·ø×´»ì×Ç£¬ÑÛµ×¼û×óÑÛÊÓÈéÍ·±ß½çÇ壬ÎÞÃ÷ÏÔË®Ö×£¬ÊÓÍøĤò¨ÏÂÖ§¾²ÂöÇøÓòƬ״°µºìÉ«³öѪ£¬ÀÛ¼°»Æ°ß²¿£¬»Æ°ß²¿Ë®Ö×£¬ÖÐÐÄ°¼·´¹â²»Ç壬ÓÒÑÛÑÛµ×δ¼ûÃ÷ÏÔÒì³£¡£OCT¼ì²é£º×óÑÛÊÓÍøĤÖÐÑëºñ¶È£¨central retinal thickness,CRT)1109μm£¬×óÑۻưßÄÒÑùË®Ö×£¨Í¼1A£©¡£»¼Õß¼ÈÍùÎÞ½áºË²¡¼°ÆäËûϵͳ¼²²¡Ê·£¬ÎÞ¼Ò×åÊ·£¬ÎÞÑÛ²¿ÍâÉËÊ·£¬Æ½Ê±ÑªÑ¹Õý³££¬µ±ÈÕѪѹ135/80 mm Hg£¬Æ½ËØÐÔÇéÒ×ÒÖÓô£¬³£ÐÄ·³Ê§Ãߣ¬ÑÛÄ¿ÕÍÍ´£¬Å¼¸ÐÍ·ÔΡ¢ÐØвÕÍÃÆ£¬¶þ±ãµ÷£¬Éàºì£¬Ì¦°×£¬ÂöÏÒɬ¡£Î÷Ò½Õï¶Ï£º£¨1£©×óÑÛÊÓÍøĤ·ÖÖ§¾²Âö×èÈû£»£¨2£©×óÑۻưßË®Ö×£»£¨3£©Ë«ÑÛÀÏÄêÐÔ°×ÄÚÕÏ¡£ÖÐÒ½Õï¶Ï£º×óÑÛ±©Ã¤£¨¸ÎÓôѪðöˮ֤ͣ£©¡£Ö稣ºÊè¸Î½âÓô£¬»îѪÀûË®¡£ÓèÒÔåÐңɢ¼Ó¼õ£¬·½Ó㺲ñºú10 g¡¢µ±¹é10 g¡¢°×ÉÖ10 g¡¢°×Êõ10 g¡¢ÜòÜß15 g¡¢Ö˸ʲÝ5 g¡¢ÌÒÈÊ10 g¡¢ºì»¨5 g¡¢³µÇ°×Ó30 g£¨°ü¼å£©¡¢ÖíÜß15 g¡¢ÔóÀ¼15 g¡¢ÕäÖéĸ10 g£¨°ü¼å£©¡¢Ò¹½»ÌÙ10 g¡£¹²10¼Á£¬Ã¿ÈÕ1¼Á£¬Ë®¼å·þ£¬·ÖÁ½´Î·þÓá£Í¬Ê±¿Ú·þÖгÉҩɢѪÃ÷ĿƬ£¬¾Ö²¿µãÆßÒ¶ÑóµØ»ÆË«ÜÕµÎÑÛÒº¡£

¡¡¡¡¶þÕ2019Äê9ÔÂ26ÈÕ£¬»¼Õß×óÑÛÊÓÎïÄ£ºý½ÏÇ°ºÃת£¬Ë¯Ã߸ÄÉÆ£¬Å¼¸ÐÍ·ÔΡ¢ÐØвÕÍÃÆ£¬ÉàÓÐðöµã£¬ÂöÏÒ¡£Õï¼û£º×óÑÛÊÓÁ¦0.2£¬½ÃÕý²»Ìá¸ß£¬ÑÛµ×¼û×óÑÛÊÓÈéÍ·±ß½çÇ壬ÎÞÃ÷ÏÔË®Ö×£¬ÊÓÍøĤò¨ÏÂÖ§¾²ÂöÇøÓòƬ״³öѪ£¬»Æ°ßË®Ö×Ã÷ÏÔ¼õÇᣬÖÐÐÄ°¼·´¹â²»Çå¡£OCT¼ì²é£º×óÑÛCRT 383μm£¨Í¼1B£©¡£Ô­·½È¥ÕäÖéĸ¡¢Ò¹½»ÌÙ£¬¼ÓÏ㸽10 g¡¢Óô½ð10 g¡£¹²15¼Á£¬Ã¿ÈÕ1¼Á£¬Ë®¼å·þ£¬·ÖÁ½´Î·þÓã¬Óàͬǰ¡£

¡¡¡¡ÈýÕ2019Äê10ÔÂ14ÈÕ£¬»¼ÕßÍ·ÔΡ¢ÐØвÕÍÃÆÖ¢×´Ïûʧ£¬Õï¼û£º×óÑÛÊÓÁ¦0.25£¬½ÃÕý²»Ìá¸ß£¬ÑÛµ×¼û×óÑÛÊÓÈéÍ·±ß½çÇ壬ÎÞÃ÷ÏÔË®Ö×£¬ÊÓÍøĤò¨ÏÂÖ§¾²ÂöÇøÓòƬ״³öѪÉÔ΢¼õÉÙ£¬»Æ°ßË®Öײ»Ã÷ÏÔ£¬ÖÐÐÄ°¼·´¹â²»Çå¡£OCT¼ì²é£ºCRT 233μm£¨Í¼1C£©¡£Ô­·½¼ÓµØÁú10 g¡¢ÈýÆß·Û3 g£¨³å·þ£©¡£¹²20¼Á£¬Ã¿ÈÕ1¼Á£¬Ë®¼å·þ£¬·ÖÁ½´Î·þÓã¬Óàͬǰ¡£

¡¡¡¡ËÄÕ2019Äê11ÔÂ4ÈÕ£¬×óÑÛÊÓÁ¦»Ö¸´ÖÁ0.3£¬½ÃÕý²»Ìá¸ß£¬ÑÛµ×¼û×óÑÛÊÓÈéÍ·±ß½çÇ壬ÎÞÃ÷ÏÔË®Ö×£¬ÊÓÍøĤò¨ÏÂÖ§¾²ÂöÇøÓòƬ״³öѪ´ó²¿·ÖÎüÊÕ£¬»Æ°ßË®Ö×ÏûÍË£¬ÖÐÐÄ°¼·´¹â²»Çå¡£OCT¼ì²é£ºCRT154μm£¨Í¼1D£©¡£Ô­·½¼Óèúʵ×Ó10 g¡¢Üûε×Ó10 g£¬¹²20¼Á£¬Ã¿ÈÕ1¼Á£¬Ë®¼å·þ£¬·ÖÁ½´Î·þÓã¬Óàͬǰ¡£

¡¡¡¡Í¼1 »¼ÕßÅíijÖÎÁÆÇ°ºó¹âѧÏà¸É¶Ï²ãɨÃ裨OCT£©±ä»¯Í¼¡£
ͼ1 »¼ÕßÅíijÖÎÁÆÇ°ºó¹âѧÏà¸É¶Ï²ãɨÃ裨OCT£©±ä»¯Í¼¡£

¡¡¡¡1AÖÎÁÆÇ°×óÑÛCRT 1109μm£¬»Æ°ßÄÒÑùË®Ö×£»1B¶þÕï×óÑÛCRT383μm;1CÈýÕï×óÑÛCRT 233μm;1DËÄÕï×óÑÛCRT 154μm;1EËæ·Ã×óÑÛCRT 158μm

¡¡¡¡Ëæ·Ã£º2020Äê4ÔÂ20ÈÕ£¬»¼Õß×Ô¾õ×óÑÛÊÓÁ¦ÒѾ­»Ö¸´ÖÁ·¢²¡Ç°£¬È«ÉíÒ²ÎÞÌØÊâ²»ÊÊ£¬Õï¼û£º×óÑÛÊÓÁ¦0.5£¬½ÃÕýÎÞÖú£¬ÑÛµ×¼û×óÑÛÊÓÈéÍ·±ß½çÇ壬ÊÓÍøĤò¨ÏÂÖ§¾²ÂöÇøÓò³öѪÒѾ­È«²¿ÎüÊÕ£¬ò¨ÏÂÖ§ÊÓÍøĤ¾²ÂöѪ¹ÜÉÔ΢ÓØÇú£¬»Æ°ßÎÞË®Ö×£¬ÖÐÐÄ°¼·´¹â²»Çå¡£OCT¼ì²é£ºCRT158μm£¨Í¼1E£©¡£ÖöÍ£ÓÃÖгÉÒ©£¬¾Ö²¿¼ÌÐøµãÆßÒ¶ÑóµØ»ÆË«ÜÕµÎÑÛÒº£¬²»ÊÊËæÕï¡£

¡¡¡¡5 ¡¢Ð¡½á

¡¡¡¡´ÓÖÐÒ½ÀíÂÛ·ÖÎö£¬»Æ°ßË®Ö×µÄÖ±½Ó²¡»úΪ“Ѫðöˮͣ”£¬¶øÒýÆð“Ѫðöˮͣ”²¡Àí¸Ä±ä¶àÓëƢʧ½¡ÔË¡¢¸ÎʧÊèй¡¢ÉöÑôÆø»¯Ê§Ë¾¼°È«ÉíÆøÒõ¿÷ÐéµÈÆø»úÔ˶¯ÕÏ°­ÓйØ[17]¡£ÖÎÁÆÉÏ»îѪÀûË®·¨Ó¦¹á´©»Æ°ßË®Ö×ÖÎÁÆʼÖÕ£¬Í¬Ê±Ó¦×ñÑ­ÖÎË®¡¢ÖÎѪ±ØÖÎÆøµÄÔ­Ôò£¬ÅäºÏ½¡Æ¢ÒæÆø¡¢Êè¸Î½âÓô¡¢ÎÂÑôÒæÆø¡¢ÒæÆøÑøÒõ¼°ÀíÆøÐÐÖ͵ÈÖÎÆøÖ®·¨£¬ÖÎÁƹý³ÌÖÐÖØÓóµÇ°×ÓÒÔÀûË®£¬ÁÙ´²ÏÔʾÄܹ»´ïµ½±ê±¾¼æ¹Ë£¬¹®¹ÌÁÆЧ£¬¼õÉÙ¸´·¢µÄÄ¿µÄ[18]¡£ÏÖ´úҽѧÈÏΪ£¬»Æ°ßË®Ö׵IJúÉúÓëѪ-ÊÓÍøĤÆÁÕϵÄÆÆ»µ£¨ÄÚƤϸ°û¼äµÄ½ôÃÜÁ¬½Ó±»ÆÆ»µ¡¢ÖÜϸ°û¶ªÊ§¡¢ÊÓÍøĤɫËØÉÏƤϸ°ûË𺦵ȣ©¡¢VEGFϸ°ûÒò×Ó¼°Ñ×ÐÔϸ°ûÒò×ÓÊͷŵÈÓйأ¬Òò´Ë£¬½áºÏÏÖ´úҽѧÀíÂÛ£¬´ÓÉÏÊö¸÷·½Ãæϵͳ̽ÌÖÖÐÒ½Ò©ÖÎÁƻưßË®Ö×µÄϸ°ûºÍ·Ö×ÓÉúÎïѧ»úÖÆ£¬¿ÉΪÖÐÒ½ÁÙ´²ÖÎÁÆÌṩÏÖ´úҽѧÀíÂÛÒÀ¾Ý¡£

¡¡¡¡²Î¿¼ÎÄÏ×

¡¡¡¡[1] XU Y,RONG A,XU W,et al. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema:a real-life clinical practice study[J].BMC Ophthalmol,2017,17(1):158.
¡¡¡¡[2] ºþ±±ÖÐҽѧԺ.½ðØÑÒªÂÔ½âÒå[M].ÉϺ£:ÉϺ£¿Æѧ¼¼Êõ³ö°æÉç,1981:145.
¡¡¡¡[3]ÌÆÈÝ´¨.Ѫ֤ÂÛ[M].¹È½¨¾ü,Уע.±±¾©:ÖйúÒ½Ò©¿Æ¼¼³ö°æÉç,2011:85,117,3.
¡¡¡¡[4]ÅíÇ廪.ÑÛ¿Æ»îѪÀûË®·¨µÄÑо¿[M].±±¾©:ÖйúÖÐÒ½Ò©³ö°æÉç,2018.
¡¡¡¡[5]ÅíÇ廪,Áõºì¾ê,»Æ¶«Ïæ.ˮѪͬÖεÄÀíÂÛÔÚÑÛ¿ÆÓ¦ÓÃ[J].ÁÉÄþÖÐÒ½ÔÓÖ¾,1993,20(2):10-11.
¡¡¡¡[6]ÅíÇ廪.ÑÛ¿ÆˮѪͬÖÎÂÛ[J].½­Î÷ÖÐÒ½Ò©,1994,25(S2):9-11.
¡¡¡¡[7]ÐÏÈêö©.»ÆµÛÄÚ¾­·ÁéÊàƪ[M].Î人:»ªÖпƼ¼´óѧ³ö°æÉç,2017:356,296.
¡¡¡¡[8] KIM I,MOON SO,KIM SH,et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1(ICAM-1),vascular cell adhesion molecule 1(VCAM-1),and E-selectin through nuclear factor-kappa B activation in endothelial cells[J].J Biol Chem,2001,276(10):7614-7620.
¡¡¡¡[9] FUNATSU H,NOMA H,MIMURA T,et al. Association of vitreous inflammatory factors with diabetic macular edema[J].Ophthalmology,2009,116(1):73-79.
¡¡¡¡[10] MUTHUSAMY A,LIN CM,SHANMUGAM S,et al. Ischemia-reperfusion injury induces occludin phosphorylation/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner[J].J Cereb Blood Flow Metab,2014,34(3):522-531.
¡¡¡¡[11]ÕÅ»Ê,ȫ濾ê,Ñîл³,µÈ.¿µ°ØÎ÷ÆÕÁªºÏ²£Á§ÌåÇиîÊõ¶ÔÌÇÄò²¡ÐԻưßË®Ö×»¼Õß·¿Ë®VEGF¡¢SDF-1µÄÓ°Ïì[J].ÖйúÁÙ´²Ò©ÀíѧÓëÖÎÁÆѧ,2019,24(2):218-222.
¡¡¡¡[12]ÍõÈô¹â,ÓÈÕÑÁá.ÊÔÎöѪðöÐγɼ°ÏÖ´úÑо¿¶ÔѪðöÈÏʶµÄÉ[J].ÖйúÖÐÒ½Ò©¿Æ¼¼,2001,8(4):272-276.
¡¡¡¡[13]Îâè©.β¡Ìõ±æ[M].ÄϾ©ÖÐÒ½Ò©´óѧβ¡Ñ§½ÌÑÐÊÒ,ÕûÀí.±±¾©:ÈËÃñÎÀÉú³ö°æÉç,2005:176-177.
¡¡¡¡[14]ºÂÃ÷·Ò,·¶Ó±,ÁºÃ¯ÐÂ.³µÇ°×ÓDZÔÚ¹¦Äܵķ¢¾òÓëÀûÓÃ[J].ʱÕä¹úÒ½¹úÒ©,2015,26(10):2479-2481.
¡¡¡¡[15]¹¢·Å,Ëïò¯,ÑîÀò,µÈ.³µÇ°×ÓÓ복ǰ²ÝÀûÄò×÷ÓÃÑо¿[J].ÉϺ£ÖÐÒ½Ò©ÔÓÖ¾,2009,43(8):72-74
¡¡¡¡[16]ÔøÃÎéª,ÀîÃç,Õű´±´,µÈ.ÝãÜÂ×Ó¡¢Þ²ÜÓÈÊ¡¢³µÇ°×ÓµÄÀûË®¹¦Ð§±È½Ï[J].ÖгÉÒ©,2018,40(1):40-46.
¡¡¡¡[17]ÏîÓî,ÁõÏþÇå,Ò¦Õð,µÈ.ÅíÇ廪½ÌÊÚÔËÓûîѪÀûË®·¨ÖÎÁƲ£Á§Ìå»ýѪµÄ¾­Ñé[J].ÖйúÖÐÒ½ÑÛ¿ÆÔÓÖ¾,2019,29(3):225-227,232.
¡¡¡¡[18]½¯Åô·É,Åí¿¡,ÅíÇ廪.dzÎö»Æ°ßÊôÆ¢[J].ÖйúÖÐÒ½ÑÛ¿ÆÔÓÖ¾,2020,30(1):42-44,48.

×÷Õßµ¥Î»£ººþÄÏÖÐÒ½Ò©´óѧ
Ô­Îijö´¦£ºÅíÇ廪,ÔøÖ¾³É,Åí¿¡,ÁõÏþÇå.»Æ°ßË®Ö×µÄÖÐÒ½Ò©ÖÎÁÆ[J].ÖйúÖÐÒ½ÑÛ¿ÆÔÓÖ¾,2020,30(06):381-385.
Ïà¹Ø±êÇ©£º
  • ±¨¾¯Æ½Ì¨
  • ÍøÂç¼à²ì
  • ±¸°¸ÐÅÏ¢
  • ¾Ù±¨ÖÐÐÄ
  • ´«²¥ÎÄÃ÷
  • ³ÏÐÅÍøÕ¾